Doctors Company Highlights Neurology Malpractice Risks in New Data Series
Event summary
- The Doctors Company, the largest physician-owned medical malpractice insurer, launched a monthly series, 'Neurology Claims: March Malpractice Risk Review'.
- The review analyzes neurology malpractice claims, focusing on patient harm, negligence allegations, and a case study of neuromonitoring failures during spinal surgery.
- Julie Ritzman, Senior VP of Patient Safety and Risk Management, emphasized the use of claims data to improve clinical decision-making and communication.
- The Doctors Company serves over 120,000 healthcare professionals and organizations nationwide through its parent company, TDC Group.
The big picture
The Doctors Company's initiative reflects a growing trend among insurers to proactively engage in risk management and patient safety, moving beyond simply paying claims. This data-driven approach, while potentially enhancing reputation and reducing long-term liabilities, requires significant investment in data analysis and a willingness to share potentially sensitive information with clinicians. TDC Group's scale allows for a broader reach and influence within the healthcare risk management landscape.
What we're watching
- Data Adoption
- The success of this initiative hinges on whether clinicians and healthcare leaders actively adopt and implement the insights derived from the claims data, rather than treating it as a compliance exercise.
- Neuromonitoring
- Given the specific focus on neuromonitoring failures, regulatory scrutiny and potential litigation related to spinal surgery practices will likely intensify.
- Series Expansion
- The Doctors Company's commitment to monthly specialty-focused reviews suggests a broader strategy to leverage claims data across various medical fields, potentially impacting their market share and competitive positioning.
Related topics